The devastating diagnosis of lung cancer in patients with COPD has led to some interesting observations such as the apparent higher sensitivity to immune checkpoint inhibitors (ICIs) in patients with both diseases compared to lung cancer alone. Speaking at TSANZSRS 2019, Professor Ian Yang highlighted recent research that found in lung cancer patients treated with ...
Professor Ian Yang: exploring coexisting COPD and lung cancer
By Mardi Chapman
12 Apr 2019